Mr Andreas Rötheli > Lenz & Staehelin > Geneva, Switzerland > Lawyer Profile

With capabilities across the financial services, chemical, life sciences and TMT sectors, Lenz & Staehelin utilises its bench strength to advise on public takeovers, private transactions and corporate governance matters. The team is recommended for its ‘experience, technical knowledge, commercial judgement and network among Swiss corporates’. Tino Gaberthüel and Andreas Rötheli co-helm the practice; the former is based in Zurich and the latter in Geneva. Stephan Erni is a strong choice for private equity and equity capital markets transactions, while Jacques Iffland is routinely engaged to handle transactions involving public companies. Matthias Wolf’s experience in the banking and financial sector further strengthens the practice, while Simone Ehrsam is trusted by clients from the public and private sectors.

The team at Lenz & Staehelin acts for a broad range of clients across the biotech, diagnostics, and medical device industries on a wide range of matters, including IP disputes concerning supplementary protection certificates (SPC), and generics and biosimilars. The team is jointly led by Thierry Calame, Harold Frey, Xavier Favre-Bulle, Andreas Rötheli, and Guy Vermeil. In Geneva, Rötheli handles private equity buyouts and real estate issues; Vermeil maintains a technology and outsourcing based practice; and Favre-Bulle is noted for his longstanding experience in arbitrations concerning licences, joint ventures, and post-M&A disputes. In Zurich, IP expert Calame assists clients with licensing issues and copy right litigation, while Frey often handles international arbitrations and cases before Swiss courts, with his main area of focus being general contractual disputes.